Pharmafile Logo
Pharmafocus logo
Advanced Search

ASCO

Showing 15 posts of 56 posts found.

abbvie_0

AbbVie says Stemcentrx’ lung cancer drug shows some benefits in early trials

June 6, 2016
Manufacturing and Production, Research and Development, Sales and Marketing ASCO, AbbVie, Stemcentrx, drug trial, lung cancer, rova-t

US drug firm AbbVie (NYSE: ABBV) said its early-stage trials for its drug to treat an aggressive form of lung …

News
abbvie_0

AbbVie says Stemcentrx’ stem cell drug shows some benefits in early trials

June 6, 2016
Manufacturing and Production, Research and Development, Sales and Marketing ASCO, AbbVie, Stemcentrx, drug trial, lung cancer, rova-t

US drug firm AbbVie (NYSE: ABBV) said its early-stage trials for its drug to treat an aggressive form of lung …

News

Mylan’s breast cancer biosimilar matches Roche’s Herceptin in Phase III trial

June 6, 2016
Research and Development ASCO, Biocon, Herceptin, Mylan, Roche, biosimilar, breast cancer, trastuzumab

Mylan (NASDAQ: MYL) and Biocon (NSE: BIOCON) have presented data the 2016 American Society of Clinical Oncology (ASCO) annual meeting …

News
opdivo_1

Bristol-Myers Squibb presents Opdivo data at ASCO

June 6, 2016
Research and Development, Sales and Marketing ASCO, Bristol-Myers Squibb, opdivo

Bristol-Myers Squibb (NYSE: BMY) has presented a wide range of results on Opdivo (nivolumab) in a range of oncology indications …

News
janssen_latest_logo_on_sign_closer

Janssen says combination Phase III study for immunotherapy Darzalex for multiple myeloma shows significant PFS

June 6, 2016
Research and Development, Sales and Marketing ASCO, Drig Trial, Janssen, multiple myeloma

Janssen said combination late stage trials for its immunotherapy drug to treat multiple myeloma showed 61% progression-free survival.  The company …

News
ASCO image

ASCO 2015 roundup: immuno-oncology hits its stride

June 8, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ASCO, BMS, CLL, pdl1

One year can make all the difference. The 2014 American Society of Clinical Oncology (ASCO) meeting took place just weeks …

Feature
AZ image

AstraZeneca lung drug shines on

June 1, 2015
Sales and Marketing ASCO, AZD9291, AstraZeneca, MEDI4736, NSCLC, Tafinlar

AstraZeneca’s investigational drug AZD9291 is continuing to impress, with results announced at cancer conference ASCO building on its previous ‘unprecedented’ …

News
yervoy image

BMS immunotherapy combination impresses at ASCO

June 1, 2015
Research and Development, Sales and Marketing ASCO, BMS, Yervoy, opdivo

Bristol-Myers Squibb has presented data showing that a combination of its immunotherapies Opdivo and Yervoy significantly increases survival in advanced …

News

Pfizer breast cancer drug delivers

June 1, 2015
Sales and Marketing ASCO, AZ, Faslodex, Pfizer, breast cancer, brett wells

A Phase III study on Pfizer’s treatment Ibrance in combination with hormone therapy has revealed the drug more than doubled …

News
Opdivo

BMS’ Opdivo improves lung cancer survival

May 29, 2015
Research and Development, Sales and Marketing ASCO, BMS, Bristol-Myers Squibb, NSCLC, lung cancer, nivolumab, non-small cell lung cancer, opdivo

A Phase III trial of Bristol-Myers Squibb’s immunotherapy Opdivo has found it increases overall survival in people with a common …

News
Novartis image

Novartis reveals ASCO plans

May 27, 2015
Sales and Marketing ASCO, GSK, Novartis

Novartis’ first ASCO conference since buying GlaxoSmithKline’s oncology business will be showcasing drugs from the acquisition. The two firms swapped …

News

Industry awaits key immunotherapy results at ASCO

May 20, 2015
Research and Development, Sales and Marketing ASCO, Cancer, oncology, pharma

This year’s American Society of Clinical Oncology (ASCO) conference has a strong focus on immunotherapy, as pharma ramps up its …

News

Merck KGaA reveals ASCO plans

May 15, 2015
Sales and Marketing ASCO, Merck, Merck KGaA, Merck Serono, avelumab

Merck KGaA is the latest company to announce its slate for this year’s ASCO conference, and like other firms it …

News
Astrazeneca image

AstraZeneca eyes success in immuno-oncology combinations

May 14, 2015
Sales and Marketing ASCO, AZ, AstraZeneca, CTLA-4, MEDI4736

An investigational immuno-oncology drug combination from AstraZeneca has shown promise in its most recent trial, although concerns over its side …

News
ASCO image

Pharma reveals its ASCO presentation data

May 12, 2015
Research and Development, Sales and Marketing ASCO, AZ, AbbVie, Roche, chicago, data

AstraZeneca, Genentech and AbbVie have all revealed which cancer drugs they will show data for at The American Society of …

News

Latest content

FDA grants ODD to Nexcella’s NXC-201 as treatment for amyloid light chain amyloidosis

September 22, 2023

AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan performs well in phase 3 trial

September 22, 2023

Novo Nordisk partners with UNICEF to prevent global childhood obesity

September 21, 2023

EC approves Menarini Group’s Orserdu for breast cancer treatment

September 21, 2023

Pharmanovia acquires CNS portfolio from Sanofi

September 20, 2023